Monographie - Isavuconazonium sulfate

Poslední aktualizace :
08/05/2024

Isavuconazonium sulfate

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cresemba

äpanÏlsko, Chile, Francie, NÏmecko, Peru, USA, Velká Británie

Odkazy : Isavuconazonium sulfate

	Typ	Uveřejnění
2864	Laboratoř	Isavuconazonium (Cresemba®) - Summary of Product Characteristics Astellas Pharma 2015
3578	Laboratoř	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3644	Laboratoř	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3827	Plakát	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	Plakát	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	Plakát	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Noviny	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145	Noviny	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4801	Noviny	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales